Table 2. In Vivo Pharmacokinetics in Preclinical Speciesa.
CL (mL/min/kg) | Vss (L/kg) | t1/2 (h) | F (%) | |
---|---|---|---|---|
Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | |
Mouse | 5.33 ± 0.81 | 0.57 ± 0.10 | 2.44 ± 0.13 | 96 ± 19 |
Rat | 5.35 ± 0.65 | 0.70 ± 0.05 | 2.77 ± 0.14 | 84 ± 3 |
Dog | 0.67 ± 0.14 | 0.25 ± 0.06 | 8.86 ± 1.76 | 72 ± 22 |
The compound was administered as a solution in 20% PEG300/3% ETPGS for mouse and rat or 25% PEG300/5% Solutol for dog.